Developments in Pharmaceutical Microencapsulation in the United States

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This study examines technological considerations, commercial trends and strategies for the microencapsulation of active pharmaceutical ingredients in the United States. Existing commercial products containing microencapsulated ingredients are examined among oral, injection, and dermal delivery routes, along with market and technology trends.

Table of Contents

Developments in Pharmaceutical Microencapsulation in the United States, Executive SummaryOverviewIntroductionTechnologiesCompetitive AnalysisStrategic ConclusionsDevelopments in Pharmaceutical Microencapsulation in the United States, Total Microencapsulation MarketOverview and DefinitionsIntroductionChallengesDriversRestraintsMarket Engineering AnalysisProducts and TrendsMicroencapsulated Pharmaceutical ProductsTechnology Trends and DefinitionsCompetitive AnalysisCompetitive StructureCompany AnalysisDevelopments in Pharmaceutical Microencapsulation in the United States, Oral DeliveryMarket OverviewOverview and DefinitionsMarket Engineering AnalysisMarket DriversMarket RestraintsProducts and TrendsMarket and Technology TrendsProduct AnalysisDevelopments in Pharmaceutical Microencapsulation in the United States, Injection DeliveryMarket OverviewOverview and DefinitionsMarket Engineering AnalysisMarket DriversMarket RestraintsProducts and TrendsMarket and Technology TrendsProduct AnalysisDevelopments in Pharmaceutical Microencapsulation in the United States, Dermal Delivery and OthersMarket OverviewOverview and DefinitionsMarket Engineering AnalysisMarket DriversMarket RestraintsProducts and TrendsMarket and Technology TrendsProduct AnalysisDevelopments in Pharmaceutical Microencapsulation in the United States, Decision Support DatabaseBiological Manufacturing EstablishmentsBiological Manufacturing EstablishmentsPharmaceutical Manufacturing CompaniesWorldwide Biotechnology Companies




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.